Escalon Medical Corp. (ESMC)
USD 0.16
(-11.11%)
USD 0.16
(-11.11%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 11.98 Million USD | -1.63% |
| 2023 | 12.18 Million USD | 13.8% |
| 2022 | 10.7 Million USD | 2.21% |
| 2021 | 10.47 Million USD | 11.4% |
| 2020 | 9.4 Million USD | -2.35% |
| 2019 | 9.62 Million USD | -15.57% |
| 2018 | 11.4 Million USD | 1.49% |
| 2017 | 11.23 Million USD | -2.95% |
| 2016 | 11.57 Million USD | -11.87% |
| 2015 | 13.13 Million USD | 6.33% |
| 2014 | 12.35 Million USD | 7.45% |
| 2013 | 11.49 Million USD | -52.97% |
| 2012 | 24.44 Million USD | -18.36% |
| 2011 | 29.94 Million USD | -5.36% |
| 2010 | 31.64 Million USD | -8.55% |
| 2009 | 34.6 Million USD | 14.53% |
| 2008 | 30.21 Million USD | -22.21% |
| 2007 | 38.83 Million USD | 30.37% |
| 2006 | 29.79 Million USD | 10.64% |
| 2005 | 26.92 Million USD | 82.9% |
| 2004 | 14.72 Million USD | 10.14% |
| 2003 | 13.36 Million USD | 10.7% |
| 2002 | 12.07 Million USD | 1.63% |
| 2001 | 11.88 Million USD | 78.11% |
| 2000 | 6.67 Million USD | -12.23% |
| 1999 | 7.6 Million USD | 28.81% |
| 1998 | 5.9 Million USD | 9.26% |
| 1997 | 5.4 Million USD | 134.78% |
| 1996 | 2.3 Million USD | 1050.0% |
| 1995 | 200 Thousand USD | 100.0% |
| 1994 | 100 Thousand USD | -94.74% |
| 1993 | 1.9 Million USD | 0.0% |
| 1992 | 1.9 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 2.94 Million USD | -6.08% |
| 2024 Q4 | 3.47 Million USD | 28.8% |
| 2024 Q2 | 2.86 Million USD | -2.57% |
| 2024 Q3 | 2.69 Million USD | -6.06% |
| 2023 Q4 | 3.13 Million USD | -8.7% |
| 2023 Q3 | 3.43 Million USD | 14.27% |
| 2023 Q1 | 2.6 Million USD | -10.52% |
| 2023 Q2 | 3 Million USD | 15.38% |
| 2023 FY | 12.18 Million USD | 13.8% |
| 2022 Q3 | 2.41 Million USD | -10.54% |
| 2022 Q1 | 2.67 Million USD | -5.64% |
| 2022 Q4 | 2.91 Million USD | 20.49% |
| 2022 FY | 10.7 Million USD | 2.21% |
| 2022 Q2 | 2.7 Million USD | 0.96% |
| 2021 Q3 | 2.32 Million USD | -19.78% |
| 2021 Q1 | 2.41 Million USD | 19.81% |
| 2021 FY | 10.47 Million USD | 11.4% |
| 2021 Q2 | 2.89 Million USD | 20.06% |
| 2021 Q4 | 2.83 Million USD | 21.93% |
| 2020 Q4 | 2.01 Million USD | -14.53% |
| 2020 Q3 | 2.35 Million USD | -13.96% |
| 2020 Q2 | 2.73 Million USD | 19.75% |
| 2020 FY | 9.4 Million USD | -2.35% |
| 2020 Q1 | 2.28 Million USD | 0.32% |
| 2019 Q4 | 2.28 Million USD | -14.54% |
| 2019 Q3 | 2.66 Million USD | 10.33% |
| 2019 Q2 | 2.41 Million USD | 7.11% |
| 2019 Q1 | 2.25 Million USD | -18.0% |
| 2019 FY | 9.62 Million USD | -15.57% |
| 2018 Q3 | 2.63 Million USD | -22.1% |
| 2018 Q1 | 2.62 Million USD | -9.16% |
| 2018 FY | 11.4 Million USD | 1.49% |
| 2018 Q4 | 2.75 Million USD | 4.5% |
| 2018 Q2 | 3.38 Million USD | 28.65% |
| 2017 Q2 | 3.16 Million USD | 35.62% |
| 2017 Q3 | 2.84 Million USD | -10.02% |
| 2017 Q4 | 2.89 Million USD | 1.73% |
| 2017 FY | 11.23 Million USD | -2.95% |
| 2017 Q1 | 2.33 Million USD | -13.93% |
| 2016 Q3 | 3.09 Million USD | 3.62% |
| 2016 Q2 | 2.98 Million USD | 7.46% |
| 2016 Q4 | 2.7 Million USD | -12.52% |
| 2016 Q1 | 2.78 Million USD | -17.68% |
| 2016 FY | 11.57 Million USD | -11.87% |
| 2015 Q3 | 3.42 Million USD | -7.35% |
| 2015 FY | 13.13 Million USD | 6.33% |
| 2015 Q1 | 2.63 Million USD | -12.13% |
| 2015 Q2 | 3.69 Million USD | 40.65% |
| 2015 Q4 | 3.37 Million USD | -1.43% |
| 2014 Q2 | 3.07 Million USD | -1.65% |
| 2014 Q3 | 3.15 Million USD | 2.38% |
| 2014 Q4 | 2.99 Million USD | -5.02% |
| 2014 FY | 12.35 Million USD | 7.45% |
| 2014 Q1 | 3.13 Million USD | 9.38% |
| 2013 Q3 | 2.72 Million USD | -25.16% |
| 2013 Q2 | 3.64 Million USD | 60.42% |
| 2013 Q1 | 2.26 Million USD | -62.68% |
| 2013 FY | 11.49 Million USD | -52.97% |
| 2013 Q4 | 2.86 Million USD | 5.03% |
| 2012 Q3 | 6.06 Million USD | -3.39% |
| 2012 Q4 | 6.08 Million USD | 0.24% |
| 2012 FY | 24.44 Million USD | -18.36% |
| 2012 Q1 | 7.02 Million USD | -4.65% |
| 2012 Q2 | 6.27 Million USD | -10.56% |
| 2011 Q2 | 7.6 Million USD | 1.63% |
| 2011 FY | 29.94 Million USD | -5.36% |
| 2011 Q4 | 7.36 Million USD | -1.85% |
| 2011 Q3 | 7.5 Million USD | -1.32% |
| 2011 Q1 | 7.47 Million USD | 45.73% |
| 2010 Q1 | 8.45 Million USD | -1.69% |
| 2010 Q4 | 5.13 Million USD | -42.5% |
| 2010 FY | 31.64 Million USD | -8.55% |
| 2010 Q3 | 8.92 Million USD | 0.48% |
| 2010 Q2 | 8.88 Million USD | 5.09% |
| 2009 Q4 | 8.59 Million USD | -6.58% |
| 2009 FY | 34.6 Million USD | 14.53% |
| 2009 Q3 | 9.2 Million USD | 13.66% |
| 2009 Q2 | 8.09 Million USD | -6.89% |
| 2009 Q1 | 8.69 Million USD | 13.92% |
| 2008 Q2 | 7.49 Million USD | 8.73% |
| 2008 Q4 | 7.63 Million USD | -6.75% |
| 2008 Q3 | 8.18 Million USD | 9.24% |
| 2008 FY | 30.21 Million USD | -22.21% |
| 2008 Q1 | 6.89 Million USD | -7.77% |
| 2007 Q3 | 16.55 Million USD | 116.83% |
| 2007 FY | 38.83 Million USD | 30.37% |
| 2007 Q4 | 7.47 Million USD | -54.86% |
| 2007 Q2 | 7.63 Million USD | 6.54% |
| 2007 Q1 | 7.16 Million USD | -0.55% |
| 2006 Q3 | 7.83 Million USD | 7.24% |
| 2006 Q1 | 7.79 Million USD | -3.09% |
| 2006 Q2 | 7.31 Million USD | -6.2% |
| 2006 Q4 | 7.2 Million USD | -8.06% |
| 2006 FY | 29.79 Million USD | 10.64% |
| 2005 Q4 | 8.04 Million USD | 11.24% |
| 2005 Q3 | 7.22 Million USD | 14.06% |
| 2005 Q2 | 6.33 Million USD | 19.76% |
| 2005 Q1 | 5.29 Million USD | 34.37% |
| 2005 FY | 26.92 Million USD | 82.9% |
| 2004 Q1 | 3.41 Million USD | -7.88% |
| 2004 Q4 | 3.93 Million USD | 9.01% |
| 2004 Q3 | 3.61 Million USD | -3.86% |
| 2004 Q2 | 3.75 Million USD | 10.15% |
| 2004 FY | 14.72 Million USD | 10.14% |
| 2003 Q1 | 3 Million USD | -1.7% |
| 2003 Q3 | 3.38 Million USD | 3.66% |
| 2003 FY | 13.36 Million USD | 10.7% |
| 2003 Q4 | 3.7 Million USD | 9.35% |
| 2003 Q2 | 3.26 Million USD | 8.6% |
| 2002 Q4 | 3.06 Million USD | -6.3% |
| 2002 FY | 12.07 Million USD | 1.63% |
| 2002 Q3 | 3.26 Million USD | 15.34% |
| 2002 Q2 | 2.83 Million USD | -2.88% |
| 2002 Q1 | 2.91 Million USD | -7.68% |
| 2001 FY | 11.88 Million USD | 78.11% |
| 2001 Q2 | 2.93 Million USD | -0.76% |
| 2001 Q1 | 2.95 Million USD | 31.53% |
| 2001 Q4 | 3.15 Million USD | 11.81% |
| 2001 Q3 | 2.82 Million USD | -3.84% |
| 2000 Q3 | 2.1 Million USD | 134.39% |
| 2000 Q2 | 900 Thousand USD | -35.71% |
| 2000 Q1 | 1.4 Million USD | -33.33% |
| 2000 FY | 6.67 Million USD | -12.23% |
| 2000 Q4 | 2.25 Million USD | 6.68% |
| 1999 Q4 | 2.1 Million USD | 0.0% |
| 1999 FY | 7.6 Million USD | 28.81% |
| 1999 Q1 | 1.7 Million USD | 13.33% |
| 1999 Q2 | 1.8 Million USD | 5.88% |
| 1999 Q3 | 2.1 Million USD | 16.67% |
| 1998 Q3 | 1.5 Million USD | 0.0% |
| 1998 FY | 5.9 Million USD | 9.26% |
| 1998 Q4 | 1.5 Million USD | 0.0% |
| 1998 Q2 | 1.5 Million USD | 7.14% |
| 1998 Q1 | 1.4 Million USD | 7.69% |
| 1997 Q3 | 1.4 Million USD | 7.69% |
| 1997 Q4 | 1.3 Million USD | -7.14% |
| 1997 Q1 | 1.4 Million USD | 7.69% |
| 1997 FY | 5.4 Million USD | 134.78% |
| 1997 Q2 | 1.3 Million USD | -7.14% |
| 1996 Q4 | 1.3 Million USD | 30.0% |
| 1996 Q3 | 1 Million USD | 900.0% |
| 1996 Q2 | 100 Thousand USD | 0.0% |
| 1996 Q1 | 100 Thousand USD | 0.0% |
| 1996 FY | 2.3 Million USD | 1050.0% |
| 1995 Q2 | 100 Thousand USD | 0.0% |
| 1995 FY | 200 Thousand USD | 100.0% |
| 1995 Q4 | - USD | -100.0% |
| 1995 Q3 | 200 Thousand USD | 100.0% |
| 1995 Q1 | 100 Thousand USD | 0.0% |
| 1994 Q2 | 100 Thousand USD | 0.0% |
| 1994 Q3 | 100 Thousand USD | 0.0% |
| 1994 Q1 | 100 Thousand USD | -85.71% |
| 1994 FY | 100 Thousand USD | -94.74% |
| 1994 Q4 | - USD | -100.0% |
| 1993 Q3 | 400 Thousand USD | -33.33% |
| 1993 FY | 1.9 Million USD | 0.0% |
| 1993 Q2 | 600 Thousand USD | 200.0% |
| 1993 Q4 | 700 Thousand USD | 75.0% |
| 1993 Q1 | 200 Thousand USD | 0.0% |
| 1992 FY | 1.9 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 714.7 Thousand USD | -1576.42% |
| IR-Med Inc. | - USD | -Infinity% |
| Polarean Imaging plc | 890.93 Thousand USD | -1244.827% |
| Medical Supply International USA, Inc. | 2.81 Million USD | -325.27% |
| Avitar, Inc. | 3.1 Million USD | -285.725% |
| AVITA Medical, Inc. | 50.56 Million USD | 76.303% |
| Manhattan Scientifics, Inc. | - USD | -Infinity% |
| Össur hf. | 785.68 Million USD | 98.475% |
| Zecotek Photonics Inc. | 86.61 Thousand USD | -13733.863% |
| QHSLab, Inc. | 1.4 Million USD | -750.359% |
| Wellstar International, Inc. | - USD | -Infinity% |
| Össur hf. | 785.68 Million USD | 98.475% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 52.61 Million USD | 77.226% |
| Aurora Spine Corporation | 14.52 Million USD | 17.485% |
| BrainsWay Ltd. | 31.78 Million USD | 62.305% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 257.39 Thousand USD | -4554.839% |
| Hamilton Thorne Ltd. | 68.45 Million USD | 82.498% |
| Vivos Inc. | 19.5 Thousand USD | -61343.636% |
| MicroPort Scientific Corporation | 950.72 Million USD | 98.74% |
| Kelyniam Global, Inc. | 2.67 Million USD | -348.35% |
| REMSleep Holdings, Inc. | 203.71 Thousand USD | -5781.419% |
| CYduct Diagnostics, Inc. | 84.48 Thousand USD | -14081.986% |
| Nanomix Corporation | 15.45 Thousand USD | -77450.22% |
| Theraclion SA | 1.82 Million USD | -557.522% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 661.55 Thousand USD | -1711.127% |
| Positron Corporation | 734.66 Thousand USD | -1530.878% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.34 Million USD | -788.304% |
| Lombard Medical, Inc. | 12.16 Million USD | 1.541% |
| ALR Technologies Inc. | 7468.00 USD | -160337.989% |
| Stratec SE | 289.14 Million USD | 95.856% |
| Vycor Medical, Inc. | 1.46 Million USD | -720.312% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | - USD | -Infinity% |
| Perimeter Medical Imaging AI, Inc. | 403.53 Thousand USD | -2869.152% |
| SANUWAVE Health, Inc. | 20.39 Million USD | 41.261% |
| VMS Rehab Systems, Inc. | 71.70 USD | -16710512.273% |
| Guided Therapeutics, Inc. | 98 Thousand USD | -12126.03% |
| Ingen Technologies, Inc. | 720.67 Thousand USD | -1562.533% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | - USD | -Infinity% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 2.84 Million USD | -321.104% |
| Urologix, Inc. | 14.23 Million USD | 15.831% |
| Rapid Therapeutic Science Laboratories, Inc. | - USD | -Infinity% |
| Nexeon MedSystems Inc. | 3.3 Million USD | -262.771% |
| SS Innovations International, Inc. | 5.87 Million USD | -103.777% |
| Qualis Innovations, Inc. | 40.17 Thousand USD | -29723.296% |
| Smith & Nephew plc | 5.68 Billion USD | 99.789% |
| NIOX Group Plc | 46.84 Million USD | 74.424% |
| Fuse Medical, Inc. | 16.11 Million USD | 25.652% |
| Broncus Holding Corporation | 10.25 Million USD | -16.836% |
| Brain Scientific Inc. | 214.56 Thousand USD | -5484.119% |
| Pressure BioSciences, Inc. | 1.97 Million USD | -505.811% |
| Health Logic Interactive Inc. | - USD | -Infinity% |